Lonza Financial Statements From 2010 to 2024

LONN Stock  CHF 521.40  0.20  0.04%   
Lonza Group financial statements provide useful quarterly and yearly information to potential Lonza Group AG investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Lonza Group financial statements helps investors assess Lonza Group's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Lonza Group's valuation are summarized below:
Lonza Group AG does not presently have any fundamental ratios for analysis.
Check Lonza Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lonza Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . Lonza financial statements analysis is a perfect complement when working with Lonza Group Valuation or Volatility modules.
  
This module can also supplement various Lonza Group Technical models . Check out the analysis of Lonza Group Correlation against competitors.

Lonza Group AG Company Return On Asset Analysis

Lonza Group's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Lonza Group Return On Asset

    
  0.057  
Most of Lonza Group's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lonza Group AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Lonza Group AG has a Return On Asset of 0.057. This is 100.65% lower than that of the Healthcare sector and 100.76% lower than that of the Diagnostics & Research industry. The return on asset for all Switzerland stocks is 140.71% lower than that of the firm.

Lonza Group AG Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Lonza Group's current stock value. Our valuation model uses many indicators to compare Lonza Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lonza Group competition to find correlations between indicators driving Lonza Group's intrinsic value. More Info.
Lonza Group AG is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about  0.48  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Lonza Group AG is roughly  2.09 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lonza Group's earnings, one of the primary drivers of an investment's value.

About Lonza Group Financial Statements

Lonza Group investors use historical fundamental indicators, such as Lonza Group's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lonza Group. Please read more on our technical analysis and fundamental analysis pages.
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia and New Zealand, and internationally. The company was founded in 1897 and is headquartered in Basel, Switzerland. LONZA N operates under Diagnostics Research classification in Switzerland and is traded on Switzerland Exchange. It employs 17154 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lonza Stock Analysis

When running Lonza Group's price analysis, check to measure Lonza Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lonza Group is operating at the current time. Most of Lonza Group's value examination focuses on studying past and present price action to predict the probability of Lonza Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lonza Group's price. Additionally, you may evaluate how the addition of Lonza Group to your portfolios can decrease your overall portfolio volatility.